Linus Backert
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
Papers in
- Immunology 10
- Immunotherapy and Immune Responses 8
- T-cell and B-cell Immunology 4
- Immune Cell Function and Interaction 4
-
- vaccines and immunoinformatics approaches 5
- Co-authors
- Oliver Kohlbacher (9 shared papers)Hans‐Georg Rammensee (11 shared papers)Heiko Schuster (9 shared papers)Stefan Stevanović (8 shared papers)Sven D. Koch (2 shared papers)Henoch S. Hong (2 shared papers)Mariola Fotin‐Mleczek (2 shared papers)Ulrike Gnad-Vogt (2 shared papers)
- Journals
- OncoImmunology (2 papers)Blood (2 papers)Journal of Clinical Oncology (1 paper)Blood Cancer Journal (1 paper)Acta Neuropathologica (1 paper)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Linus Backert
18 papers receiving 1.0k citations
Linus Backert's Hit Papers
Peers
Comparison fields: 5 of 68
- Immunology 430
- Infectious Diseases 294
- Molecular Biology 641
- Virology 42
- Oncology 205
Countries citing papers authored by Linus Backert
This map shows the geographic impact of Linus Backert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linus Backert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linus Backert more than expected).
Fields of papers citing papers by Linus Backert
This network shows the impact of papers produced by Linus Backert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linus Backert. The network helps show where Linus Backert may publish in the future.
Co-authors
The 25 scholars most cited alongside Linus Backert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial Hit paper breakdown → | 2017 | 387 |
| 2 | 2015 | 150 | |
| 3 | 2014 | 108 | |
| 4 | 2017 | 89 | |
| 5 | 2015 | 74 | |
| 6 | 2017 | 70 | |
| 7 | 2018 | 36 | |
| 8 | 2018 | 30 | |
| 9 | 2017 | 28 | |
| 10 | 2016 | 18 | |
| 11 | 2016 | 17 | |
| 12 | 2016 | 15 | |
| 13 | 2017 | 15 | |
| 14 | 2017 | 10 | |
| 15 | 2014 | 5 | |
| 16 | 2018 | 5 | |
| 17 | 2016 | 3 | |
| 18 | 2020 | 1 |
About Linus Backert
Linus Backert is a scholar working on Immunology, Molecular Biology, Oncology, Genetics and Hematology, having authored 18 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), vaccines and immunoinformatics approaches (5 papers), T-cell and B-cell Immunology (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Immune Cell Function and Interaction (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lymphoma Diagnosis and Treatment (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Immunology (430 citations), Infectious Diseases (294 citations), Molecular Biology (641 citations), Virology (42 citations) and Oncology (205 citations). Linus Backert has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Oliver Kohlbacher, Hans‐Georg Rammensee, Heiko Schuster, Stefan Stevanović, Sven D. Koch, Henoch S. Hong, Mariola Fotin‐Mleczek, Ulrike Gnad-Vogt, Ingmar Hoerr and Raphaël Gottardo. Their work appears in journals such as OncoImmunology, Blood, Journal of Clinical Oncology, Blood Cancer Journal and Acta Neuropathologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.